COMPASS THERAPEUTICS INC (CMPX) Stock Earnings & Estimates
NASDAQ:CMPX - US20454B1044 - Common Stock
3.49 USD
0 (0%)
3.43 USD
-0.06 (-1.72%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 850K | -100.00% | 24.303M | 85.29M 250.94% | 205.09M 140.46% | 363.45M 77.21% | 649.9M 78.81% | 1.402B 115.73% | 2.187B 55.99% | |||
| EBITDA YoY % growth | -40.88M 49.72% | -49.664M -21.49% | -56.036M -12.83% | -81.371M -45.21% | -98.858M -21.49% | -76.021M 23.10% | -41.514M 45.39% | 28.733M 169.21% | 124.36M 332.81% | 168.03M 35.12% | 211.51M 25.88% | |
| EBIT YoY % growth | -41.66M 49.12% | -50.363M -20.89% | -56.625M -12.43% | -82.715M -46.08% | -98.045M -18.53% | -85.149M 13.15% | 25.015M 129.38% | 142.94M 471.42% | 379.12M 165.23% | 1.076B 183.82% | 1.775B 64.96% | |
| Operating Margin | N/A | N/A | -6,661.76% | N/A | -403.43% | -99.83% | 12.20% | 39.33% | 58.34% | 76.75% | 81.16% | |
| EPS YoY % growth | -0.37 69.70% | -0.34 8.11% | -0.37 -8.82% | -0.54 -47.13% | -0.58 -5.66% | -0.49 14.68% | 0.04 108.67% | 0.65 1,420.38% | 2.01 210.41% | 4.76 137.30% | 6.79 42.56% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.15 -82.71% | -0.15 -33.53% | -0.15 -23.89% | -0.14 -3.27% | -0.11 26.03% | -0.09 37.22% | -0.12 17.67% | -0.10 29.45% | -0.08 24.53% | -0.04 55.75% |
| Revenue Q2Q % growth | 3.409M | 17.057M | 5.1M | 10.2M | 15.3M 348.81% | 25.775M 51.11% | ||||
| EBITDA Q2Q % growth | -22.69M -92.45% | -23.429M -46.57% | -26.5M -52.38% | -27.377M -34.63% | -28.356M -24.97% | -28.958M -23.60% | -29.539M -11.47% | -27.601M -0.82% | -22.399M 21.01% | -14.637M 49.45% |
| EBIT Q2Q % growth | -21.399M -74.84% | -21.242M -28.17% | -21.08M -26.91% | -21.361M -1.40% | -20.744M 3.06% | -18.932M 10.88% | -22.817M -8.24% | -19.186M 10.18% | -15.555M 25.01% | -7.64M 59.65% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.14 -40.00% | -0.13 | -0.01 | -10.69% |
| Q1 2025 Q2Q % growth | -0.12 -50.00% | -0.11 | -0.01 | -5.99% |
| Q4 2024 Q2Q % growth | -0.11 | -0.10 | -0.01 | -9.93% |
| Q3 2024 Q2Q % growth | -0.08 | -0.12 | 0.04 | 30.79% |
| Q2 2024 Q2Q % growth | -0.10 -11.11% | -0.10 | 0.00 | -3.20% |
| Q1 2024 Q2Q % growth | -0.08 -33.33% | -0.12 | 0.04 | 30.51% |
| Q4 2023 Q2Q % growth | -0.11 -10.00% | -0.10 | -0.01 | -14.56% |
| Q3 2023 Q2Q % growth | -0.08 33.33% | -0.11 | 0.03 | 26.80% |
| Q2 2023 Q2Q % growth | -0.09 -12.50% | -0.08 | -0.01 | -8.36% |
| Q1 2023 Q2Q % growth | -0.06 14.29% | -0.11 | 0.05 | 45.82% |
| Q4 2022 Q2Q % growth | -0.10 52.38% | -0.11 | 0.01 | 12.85% |
| Q3 2022 Q2Q % growth | -0.12 -20.00% | -0.11 | -0.01 | -10.29% |
| Q2 2022 Q2Q % growth | -0.08 | -0.09 | 0.01 | 6.95% |
| Q1 2022 Q2Q % growth | -0.07 | -0.11 | 0.04 | 37.61% |
| Q4 2021 Q2Q % growth | -0.21 | -0.07 | -0.14 | -182.57% |
| Q3 2021 Q2Q % growth | -0.10 | -0.13 | 0.03 | 21.57% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -9.47% | -35.56% | -6.44% | -13.45% |
| Revenue | N/A | N/A | N/A | N/A |